BioHorizons, which sells dental implants and biologics for the replacement of missing teeth, withdrew its plans for an initial public offering on Tuesday, citing poor market conditions. The Birmingham, AL-based company had planned to raise $90 million early last year but postponed the deal in February. Piper Jaffray and Jefferies were set to be the joint bookrunners on the deal.
